Eiger raises $21.3M in follow-on

Orphan disease company Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) raised $21.3 million through the sale of 2.1 million shares at $10 in a follow-on underwritten by BTIG. The figure includes the sale of a 278,212 share overallotment on Oct. 31. The price is a 7% discount to the company’s close of $10.80 on Oct. 26, when the offering was announced after market hours...